WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Town Hall: Looking Back, Looking Forward

Renowned clinical kidney cancer researchers
will share a retrospective of 2021 breakthroughs,
along with a look forward at what we can expect
in 2022. Join us!

Speak Up for Research Funding

Every year, KidneyCAN sends advocates to Washington, D.C., to ask Congress to fund kidney cancer research. Our advocates are patients, caregivers, doctors, and researchers. Join us, and make a difference!

Handling the Holidays with Cancer

KidneyCAN gathered experts to share strategies for creating a “new normal” as you cope with kidney cancer during the holiday season.

Just diagnosed? Learn more.

A kidney cancer diagnosis can be scary and confusing. You’re not alone. KidneyCAN has put together resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

Kidney Cancer Research Summit 2021

KCRS21 took place on October 7-8, 2021. View video and slides of presentations to get the latest kidney cancer research news.

Making Progress Toward Cures

Our Goals

  • We provide education, resources, and support to kidney cancer patients and caregivers
  • We identify patients’ and researchers’ unmet needs
  • We engage and educate policymakers on the urgency of kidney cancer research funding
  • We urge Congress to fund kidney cancer research
  • We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • We provide direct funding to promising ideas
  • We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • We grow the community of kidney cancer researchers
  • We support the development of new treatments by educating patients on trial access and enrollment
  • We identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

For Patients

Advocacy

Research

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

1/ The long-awaited OS results from #KEYNOTE-564 are out @NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC.

https://t.co/8hGQjmqZr6

🚨📢Just published! The first trial that showed an overall survival benefit in patients with renal cell carcinoma in the adjuvant setting (KEYNOTE-564) out in @NEJM 🚨 ⭐️💫

...@DrChoueiri @DanaFarber @tompowles1 @OncoAlert @DanaFarber_GU

https://t.co/vp6bKfppfj

Registration is open for the KidneyCAN town hall on clinical trials: @kidneycan

@kidneycan
@kidneycan6 days ago

"In 2016, I was blindsided with a stage IV #kidneycancer diagnosis. I thought I was going to die. The five-year survival rate that year for metastatic #RCC patients was 5%." -- @LauraEsfeller, on the other side of her participation in a clinical trial

👉https://bit.ly/RealTalkTrials

The @OncoAlert 🚨ROUND UP
Covering April 5th-12th, 2024

REGISTER at http://www.OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration

...Discussing:
✅ @US_FDA 🇺🇸approval trastuzumab dx
https://t.co/BrgqHGXWzV

✅ Durvalumab in🫁 Small Cell #LungCancer
https://t.co/FiE5iz8YSm

✅ Alina out…

"In 2016, I was blindsided with a stage IV #kidneycancer diagnosis. I thought I was going to die. The five-year survival rate that year for metastatic #RCC patients was 5%." -- ...@LauraEsfeller, on the other side of her participation in a clinical trial

👉https://bit.ly/RealTalkTrials

Guided by a rich portfolio of ongoing efforts, @theNCI is seizing opportunities to fund new health disparities studies, diversify our pipeline of talent, and ensure that clinical studies include and ...benefit minority populations. #HealthDisparities

Image for twitter card
Research Areas - Cancer Health Disparities

NCI is addressing cancer health disparities through its efforts in basic research, community-level programs, and more.

When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $135 million in research funding in five years.

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available...

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H...

Voices of Resilience: Navigating Kidney Cancer in Veteran and Native American Communities

On the outskirts of Tulsa, Oklahoma, Maggie Burns stands as a testament to resilience and advocacy within the kidney cancer community. A caregiver to her husband, Ron Stanton, Maggie is a proud member of the Cherokee Nation and a retired IT professional. Maggie's life...

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at...

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.